ArticleESMO open2021

Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273].

M Reck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.